Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Infectious disease

INDICATION: Bacterial infection; sepsis

Cell culture and mouse studies identified an odilorhabdin-based bacterial ribosomal 30S subunit inhibitor that could help treat bacterial

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE